The Bill & Melinda Gates Foundation provided the funding for the MORDOR trial (OP1032340). Pfizer Inc. (New York City) provided both the azithromycin and the placebo oral suspensions. The Salesforce Foundation provided user licenses to Salesforce.com and cloud storage. TANA was funded by the US NIH/NEI, U10 EY016214, with azithromycin provided by Pfizer International and the International Trachoma Initiative. PRET was funded by the Bill & Melinda Gates Foundation (48027).
Porco TC et al. 2009. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 302: 962–968.
O’Brien KS et al. 2018. Childhood mortality after mass distribution of azithromycin: a secondary analysis of the PRET cluster-randomized trial in Niger. Pediatr Infect Dis J 37: 1082–1086.
Keenan JD, Ayele B, Gebre T, Zerihun M, Zhou Z, House JI, Gaynor BD, Porco TC, Emerson PM, Lietman TM, 2011. Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin Infect Dis 52: 883–888.
O’Brien KS, Emerson P, Hooper PJ, Reingold AL, Dennis EG, Keenan JD, Lietman TM, Oldenburg CE, 2019. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review. Lancet Infect Dis 19: e14–e25.
Bloch EM, West SK, Mabula K, Weaver J, Mrango Z, Muñoz B, Lietman T, Coles C, 2017. Antibiotic resistance in young children in Kilosa District, Tanzania 4 years after mass distribution of azithromycin for trachoma control. Am J Trop Med Hyg 97: 815–818.
Seidman JC, Johnson LB, Levens J, Mkocha H, Muñoz B, Silbergeld EK, West SK, Coles CL, 2016. Longitudinal comparison of antibiotic resistance in diarrheagenic and non-pathogenic Escherichia coli from young Tanzanian children. Front microbiol 7: 1420.
Skalet AH et al. 2010. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. PLoS Med 7: e1000377.
Oldenburg CE et al. 2020. Mass azithromycin distribution to prevent childhood mortality: a pooled analysis of cluster randomized trials. Am J Trop Med Hyg 100: 691–695.
Amza A et al. 2017. A cluster-randomized trial to assess the efficacy of targeting trachoma treatment to children. Clin Infect Dis 64: 743–750.
Oldenburg CE et al. 2018. Comparison of mass azithromycin coverage targets of children in Niger: a cluster-randomized trachoma trial. Am J Trop Med Hyg 98: 389–395.
Amza A et al. 2018. Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial. Br J Ophthalmol 102: 680–686.